FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067066 [Registered on: 09/05/2024] Trial Registered Prospectively
Last Modified On: 08/05/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Other 
Public Title of Study   Utility of automated control of oxygen delivery in preterm infants 
Scientific Title of Study   Influence of closed loop automated control of oxygen (CLACO) on time spent by the infant within the target saturation range, and oxygen requirement in South Indian preterm infants under 34 weeks.  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
SKSH/IEC/2024/4/62 dated 04.03.2024  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Santhanakrishnan Ramakrishnan 
Designation  Consultant Neonatal paediatrician 
Affiliation  SKS Hospital and Postgraduate Medical Institute 
Address  Clinic number 89 SKS Hospital and Postgraduate Medical Institute 23 SKS Hospital Road Alagapuram Salem
23 SKS Hospital Road Alagapuram Salem 636004
Salem
TAMIL NADU
636004
India 
Phone  9655319192  
Fax    
Email  ramakrishnan.s@sksh.ac.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Santhanakrishnan Ramakrishnan 
Designation  Consultant Neonatal paediatrician 
Affiliation  SKS Hospital and Postgraduate Medical Institute 
Address  Clinic number 89 SKS Hospital and Postgraduate Medical Institute 23 SKS Hospital Road Alagapuram Salem
23 SKS Hospital Road Alagapuram Salem 636004
Salem
TAMIL NADU
636004
India 
Phone  9655319192  
Fax    
Email  ramakrishnan.s@sksh.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr Santhanakrishnan Ramakrishnan 
Designation  Consultant Neonatal paediatrician 
Affiliation  SKS Hospital and Postgraduate Medical Institute 
Address  Clinic number 89 SKS Hospital and Postgraduate Medical Institute 23 SKS Hospital Road Alagapuram Salem
23 SKS Hospital Road Alagapuram Salem 636004
Salem
TAMIL NADU
636004
India 
Phone  9655319192  
Fax    
Email  ramakrishnan.s@sksh.ac.in  
 
Source of Monetary or Material Support  
SKS Hospital and Postgraduate Institute 23 SKS Hospital Road Alagapuram Salem 636004 
 
Primary Sponsor  
Name  Nil 
Address  Not applicable 
Type of Sponsor  Other [Not applicable] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Santhanakrishnan Ramakrishnan  SKS Hospital and Postgraduate Medical Institute  First floor NICU, Department of Neonatology and Paediatrics 23 SKS Hospital Road, Alagapuram Salem 636004
Salem
TAMIL NADU 
9655319192

ramakrishnan.s@sksh.ac.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J840||Alveolar and parieto-alveolar conditions, (2) ICD-10 Condition: J840||Alveolar and parieto-alveolar conditions, (3) ICD-10 Condition: J840||Alveolar and parieto-alveolar conditions,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Closed loop automated control of oxygen (Oxygenie, SLE 6000)  Each baby requiring respiratory support, will spend 8 hours monitored by closed loop automated control of oxygen (Oxygenie, SLE 6000 device) (CLACO arm). 
Comparator Agent  Manual Control Of Oxygen  The same babies from the intervention group requiring respiratory support will be crossed over and monitored manually by nurses, using the traditional manual control of oxygen for a period of 8 hours. (MCO arm). 
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  28.00 Day(s)
Gender  Both 
Details  Infants born under 34 weeks gestation who require respiratory support, either invasive or non-invasive ventilation, for a medical indication.  
 
ExclusionCriteria 
Details  Babies with any congenital malformation including congenital heart disease, diaphragmatic hernia, cystic pulmonary airway malformation or any other cardio respiratory malformation were excluded. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Proportion of time spent by the infants within the target oxygen saturation range will be compared between CLACO arm and MCO arm.  16 hours 
 
Secondary Outcome  
Outcome  TimePoints 
Concentration of FiO2 required to maintain target oxygen saturation compared between CLACO arm and MCO arm.  16 hours 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   As per International and National clinical guidelines, all preterm babies born under 34 weeks gestation are required to achieve a saturation target of 91- 95% to prevent hyperoxia/hypoxia related complications. Currently, nurses manually adjust oxygen supply to maintain target saturations. However, evidence shows that such manual control of oxygen (MCO) therapy is less successful in achieving precise targeted saturation in these vulnerable infants. Closed loop automated control of oxygen (CLACO) has been proven to achieve significant improvement in time spent by the infant within that targeted saturation range.

This is a prospective crossover study where each baby requiring respiratory support, will spend 8 hours monitored by closed loop automated control of oxygen (Oxygenie, SLE 6000 device) (CLACO arm). 

The same babies from the intervention group requiring respiratory support will be crossed over and monitored manually by nurses, using the traditional manual control of oxygen for a period of 8 hours.  (MCO arm).

Aims:

           Does automated control of oxygen using a CLACO device in South Indian preterm babies result in increased proportion of time spent within the targeted saturation range compared to manual control of oxygen (MCO)?

 

Objectives:

 

1)    We would like to compare the percentage of time spent by the infant in three different saturation ranges including the target saturation range between 91 to 95%. This comparison would be between the CLACO group and the MCO group. 

2)    To find out if there is any significant difference in the percentage of oxygen required to maintain target saturation range between the two groups (CLACO vs MCO). 

 
Close